Best TWAS P=3.75e-10 · Best GWAS P=1.65e-09 conditioned to 0.407
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Cells Transformed fibroblasts | C17orf80 | 0.10 | 0.10 | lasso | 5 | 0.10 | 1.2e-07 | 5.5 | -5.7 | 1.2e-08 | -0.99 | 0.03 | 0.97 | FALSE |
2 | GTEx | Colon Sigmoid | C17orf80 | 0.30 | 0.17 | enet | 10 | 0.11 | 9.1e-05 | 5.9 | -5.6 | 1.9e-08 | -0.99 | 0.02 | 0.97 | FALSE |
3 | GTEx | Esophagus Muscularis | C17orf80 | 0.13 | 0.00 | lasso | 7 | 0.00 | 2.4e-01 | 5.8 | -6.0 | 2.3e-09 | -0.86 | 0.03 | 0.86 | FALSE |
4 | GTEx | Testis | FAM104A | 0.22 | 0.11 | lasso | 6 | 0.14 | 9.8e-07 | 5.8 | -5.4 | 7.6e-08 | -0.94 | 0.02 | 0.98 | FALSE |
5 | GTEx | Testis | COG1 | 0.21 | 0.26 | lasso | 2 | 0.25 | 1.8e-11 | 5.7 | -5.7 | 1.1e-08 | -0.98 | 0.03 | 0.97 | FALSE |
6 | GTEx | Thyroid | COG1 | 0.16 | 0.12 | lasso | 3 | 0.13 | 5.1e-10 | 5.1 | 5.4 | 7.3e-08 | 0.97 | 0.02 | 0.98 | FALSE |
7 | YFS | Blood | FAM104A | 0.06 | 0.06 | enet | 15 | 0.06 | 5.5e-18 | 5.9 | -5.9 | 3.3e-09 | -1.00 | 0.01 | 0.99 | FALSE |
8 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C17orf80 | 0.04 | 0.04 | enet | 3 | 0.05 | 4.2e-05 | 5.7 | -5.4 | 5.5e-08 | -0.96 | 0.02 | 0.97 | FALSE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C17orf80 | 0.04 | 0.09 | enet | 10 | 0.10 | 5.2e-19 | 5.8 | -5.8 | 8.4e-09 | -0.99 | 0.02 | 0.98 | FALSE |
10 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | C17orf80 | 0.07 | 0.03 | enet | 6 | 0.05 | 1.1e-03 | 5.3 | -5.7 | 1.2e-08 | -0.90 | 0.02 | 0.97 | FALSE |
11 | The Cancer Genome Atlas | Colon Adenocarcinoma | C17orf80 | 0.11 | 0.08 | blup | 52 | 0.07 | 1.2e-04 | 5.5 | -5.1 | 2.8e-07 | -0.96 | 0.03 | 0.97 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C17orf80 | 0.04 | 0.04 | lasso | 3 | 0.03 | 1.6e-04 | 6.0 | -6.0 | 1.5e-09 | -0.99 | 0.01 | 0.98 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C17orf80 | 0.10 | 0.16 | lasso | 2 | 0.14 | 1.1e-08 | 5.9 | -6.0 | 2.6e-09 | -0.97 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C17orf80 | 0.02 | 0.02 | lasso | 2 | 0.01 | 1.9e-02 | 5.9 | -5.9 | 3.1e-09 | -0.97 | 0.01 | 0.83 | FALSE |
15 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C17orf80 | 0.06 | 0.09 | blup | 49 | 0.09 | 6.7e-11 | 5.5 | -6.0 | 2.6e-09 | -0.95 | 0.03 | 0.97 | FALSE |
16 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C17orf80 | 0.06 | 0.09 | enet | 6 | 0.08 | 6.0e-06 | 5.1 | -5.5 | 4.2e-08 | -0.98 | 0.04 | 0.96 | FALSE |
17 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C17orf80 | 0.13 | 0.14 | lasso | 3 | 0.15 | 1.1e-06 | 4.5 | -5.2 | 2.6e-07 | -0.95 | 0.02 | 0.98 | FALSE |
18 | The Cancer Genome Atlas | Soft Tissue Sarcoma | C17orf80 | 0.06 | 0.04 | blup | 49 | 0.04 | 1.8e-03 | 6.0 | -6.3 | 3.7e-10 | -0.91 | 0.01 | 0.72 | TRUE |
19 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C17orf80 | 0.10 | 0.13 | lasso | 3 | 0.12 | 3.1e-09 | 5.1 | -5.6 | 2.5e-08 | -0.92 | 0.03 | 0.97 | FALSE |
20 | The Cancer Genome Atlas | Thyroid Carcinoma | C17orf80 | 0.06 | 0.12 | lasso | 3 | 0.11 | 4.3e-11 | 5.8 | -5.9 | 3.2e-09 | -0.99 | 0.01 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Thyroid Carcinoma | FAM104A | 0.03 | 0.00 | blup | 55 | 0.01 | 2.9e-02 | 5.8 | 6.2 | 4.5e-10 | 0.87 | 0.01 | 0.75 | FALSE |